In this regard, recent trials have shown that, in a selection of patients undergoing cardiac surgery, using blood biomarkers associated with high risk for acute kidney injury (AKI) (like TIMP-2) reduced the rate and severity of AKI [109, 110]. Here, TIMP2 is linked to acute kidney injury.